Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.40 |
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.38 |
| ▸ | HINT1 | P49773 | 1/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8533343 | 0.91 | HINT1 (0.40) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8530371 | 0.87 | HINT1 (0.40) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8528882 | 0.85 | HINT1 (0.45) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8529223 | 0.85 | HINT1 (0.45) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8529436 | 0.85 | ALDH1A1 (0.48) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8529887 | 0.84 | HINT1 (0.40) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8533171 | 0.82 | HINT1 (0.40) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8529066 | 0.81 | CYP2C19 (0.48) | ADORA2AADORA2BSLC29A1ADORA1CYP2C19 | |
| SCHEMBL8530375 | 0.81 | P2RX3 (0.46) | ADORA2AADORA2BSLC29A1HINT1NT5E | |
| SCHEMBL8529155 | 0.80 | ALDH1A1 (0.52) | ADORA2AADORA2BSLC29A1HINT1NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5821236-A | Tumor treatment with arabinofuranosyl purine derivatives | GLAXO WELLCOME INC. (US) | 1998-10-13 | — | — | US | disclosed |
| US-5747472-A | ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS | GLAXO WELLCOME INC. (US) | 1998-05-05 | — | — | US | disclosed |
| US-5492897-A | ANTITUMOR AGENTS, AUTOIMMUNE DISEASES | BURROUGHS WELLCOME CO. (141) (US) | 1996-02-20 | — | — | US | disclosed |
| US-5424295-A | Useful in treatment of varicella-zoster virus infections | BURROUGHS WELLCOME CO. (US) | 1995-06-13 | — | — | US | disclosed |
| WO-1992001456-A1 | HETEROCYCLIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-02-06 | — | — | WO | disclosed |